Urol. praxi, 2015; 16(4): 144-147
Retroperitoneal lymph node dissection as a treatment choice of testicular cancer
- Urologická klinika LF UP a FN, Olomouc
Non-seminoma germ cell tumor (NSGCT) represent 40–50 % of testicular cancer. Multinodal approach including combination of surveillance,
chemotherapy and RPLND. Prior to the introduction of chemotherapy, RPLNP was the only treatment method following radical
orchiectomy. Particularly due to the challenging nature nad numerus complications of classic open RPLND, adjutant therapy is the
method of choice in non-seminoma testicular cancer. The introduction of a modified and nerve-sparing technice has reduced rate of
intraoperative complications and significantly improves postoperative corse including ejaculatory dysfunction. Technically challenging
salvage lymphadenectomy, which makes nerve-sparing techniques difficult, still plays a key role in the management of advanced NSGCT.
Keywords: retroperitoneal lymph node dissection, testicular cancer
Published: November 1, 2015 Show citation
References
- Kawaciuk I. Nádory varlat. Urologie. Praha. Galén, 2009: 408-409.
- Tošovský V, Abrahámová J, et al. Kryptorchizmus, Praha: Triton, 2004.
- Lashley DB, Lowe BA. A rational approach to managing stage I nonseminematous germ cell cancer. Urol Clin North Am 1998; 25(3): 405-423.
Go to original source... 
Go to PubMed... - Ondruš D, Goncalves F, Kausitz J, Matoška J, Belan V. The value of prognosstic factors in the management of stage I nonseminematous germ cell testicular tumors (NSGCT). Neoplasma 1996; 43(3): 195-197. Go to PubMed...
- Abrahámová J. Testicular tumours, Management and treatment Acta Univ. Carolinae monogr. CXXXVIII, Praha, 1990.
- Albers P, Albrecht W, Algaba F, Bokermeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP. Guidelines on Testicular Cancer in EAU Guidelines. 2014 Edition, Arnhem, 12-15.
- Hendry WF, Norman A, Nicols J, Deanlaley DP, Peckham MJ, Horwick A, Abdominal relace in stage I nonseminematous germ cell tumours of the testis managed by surveillance or with adjutant chemotherapy, BJU Int. 2000; 86(1): 89-93. Go to original source... Go to PubMed...
- Spermon JR, Roeleveld TA, van der Poel HG, Hulsbergen van de Kaa CA, Ten Bokkel Huinink WW, van de Vijver M, Witjes JA, Horenblas S. Comparison of surveillance and retroperitoneal lymph node dissection in stage I nonseminematous germ cell tumours. Urology 2002; 59(6): 923-929. Go to original source... Go to PubMed...
- Foster RS, Roth BJ. Clinical stage I nonseminoma: surgery versus surveillance. Semin Oncol 1998; 25(2): 145-153.
- Foster RS. Modified retroperitoneal lymphadenectomy, BJU Int 2004; 94: 941-955. Go to original source... Go to PubMed...
- Fossa SD, Kleep O, Ous S, et al. Unilateral retroperitoneal lymph node dissection in patiens with nonseminomatous testicular tumor in clinical stage I. Eur Urol 1894; 10: 17-23. Go to original source...
- Artura HO, Paula AAP, Suarez R, et al. Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy? Inter Braz J Urol 2003; 29: 412-417. Go to original source...
- Janetschek G, Hobish A, Hotl L, et al. Retroperitoneal lymphadenectomy for clinical stage I nonseminatous testicular tumor: laparoscopy versus open surgery and impact of leasing curve. J Urol 1996; 156(1): 89-93. Go to original source... Go to PubMed...
- Heidenreich A, Albert P, Hartmann M, et al. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the german testicular cancer study group. J Urol 2003; 169: 1710-1714. Go to original source... Go to PubMed...
- Pizzocaro G. Reotroperitoneal lymphadenectomy in clinical stage I nonseminomatous Terminal testicular cancer, Eur J Surg, Oncol 1986; 12: 25-28.
- Schmidt M, Hanek P, Veselý S, Dušek P. Laparoskopicky modifikovaná retroperitoneální lymfadenektomie. Urol. praxi, 2010; 11(6): 319-322.
- Albqami N, Janetschek G. Laparoscopic retroperitoneal lymph node dissection in the management of the clinical stage I and II testicular cancer. J Endourol 2005; 19(6): 683-692. Go to original source... Go to PubMed...
- Steiner H, Peschel R, Janetschek G, Höltl L, Berger AP, Bartsch G, Hoblisch A. Long term results of laparoscopic retroperitoneal lymph node dissection a single centre 10-year experience. Urology, 2004; 63(3): 550-555. Go to original source... Go to PubMed...
- Maldonado-Valdez R, Schilling D, Anastasiadis AG, Sturm W, Stenzl A, Corvin S. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in testis cancer patiens. J Endourol, 2007; 21(12): 1501-1504. Go to original source... Go to PubMed...
- Permpongkosol S, Lima GC, Warlick CA, Allaf ME, Varkarakis IM, Bagga HS, Kohamin S, Kavoussi LR. Postchemotherapy laparoscopic retroperitoneal lymph node dissection evaluation of complications. Urology, 2007; 69(2): 361-365. Go to original source... Go to PubMed...
- Jewett MA, Kang Y, Goldberg SD, et al. Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J. Urol 1988; 139: 1220-1224. Go to original source... Go to PubMed...
- Donahue JP, Foster RS, Rowland RG, et al. Nerve sparing retroperitoneal lymphadenectomy with preservativ of ejaculation. J. Urol 1993; 144: 287-292. Go to original source...